Cochlear Limited (ASX: COH)
Australia
· Delayed Price · Currency is AUD
315.10
-2.17 (-0.68%)
Jul 3, 2024, 4:10 PM AEST
Cochlear Revenue
Cochlear had revenue of 2.18B AUD in the twelve months ending December 31, 2023, with 39.00% growth year-over-year. Revenue in the quarter ending December 31, 2023 was 1.11B AUD with 36.56% year-over-year growth. In the fiscal year ending June 30, 2023, Cochlear had annual revenue of 1.96B AUD with 19.17% growth.
Revenue (ttm)
2.18B
Revenue Growth
+39.00%
P/S Ratio
9.50
Revenue / Employee
453,437
Employees
4,800
Market Cap
20.64B AUD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2023 | 1.96B | 314.60M | 19.17% |
Jun 30, 2022 | 1.64B | 147.80M | 9.90% |
Jun 30, 2021 | 1.49B | 141.00M | 10.43% |
Jun 30, 2020 | 1.35B | -74.40M | -5.21% |
Jun 30, 2019 | 1.43B | 63.00M | 4.62% |
Jun 30, 2018 | 1.36B | 109.90M | 8.77% |
Jun 30, 2017 | 1.25B | 123.25M | 10.90% |
Jun 30, 2016 | 1.13B | 204.92M | 22.14% |
Jun 30, 2015 | 925.63M | 120.69M | 14.99% |
Jun 30, 2014 | 804.94M | 52.22M | 6.94% |
Jun 30, 2013 | 752.72M | -26.28M | -3.37% |
Jun 30, 2012 | 779.00M | -30.65M | -3.79% |
Jun 30, 2011 | 809.65M | 74.84M | 10.19% |
Jun 30, 2010 | 734.80M | 40.10M | 5.77% |
Jun 30, 2009 | 694.70M | 92.97M | 15.45% |
Jun 30, 2008 | 601.73M | 42.31M | 7.56% |
Jun 30, 2007 | 559.41M | 107.15M | 23.69% |
Jun 30, 2006 | 452.26M | 107.41M | 31.15% |
Jun 30, 2005 | 344.85M | 62.08M | 21.95% |
Jun 30, 2004 | 282.77M | -5.80M | -2.01% |
Jun 30, 2003 | 288.58M | 33.60M | 13.18% |
Jun 30, 2002 | 254.98M | 34.87M | 15.84% |
Jun 30, 2001 | 220.11M | - | - |
Jun 30, 2000 | 0 | - | - |
Jun 30, 1999 | 0 | - | - |
Jun 30, 1998 | 0 | - | - |
Jun 30, 1997 | 72.92M | 648.00K | 0.90% |
Jun 30, 1996 | 72.28M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
CSL Limited | 31.85B |
ResMed Inc. | 6.66B |
Fisher & Paykel Healthcare Corporation Limited | 1.60B |
Pro Medicus Limited | 142.12M |
Sonic Healthcare Limited | 8.21B |
Ramsay Health Care Limited | 15.96B |
Telix Pharmaceuticals Limited | 502.55M |
Neuren Pharmaceuticals Limited | 231.93M |
Cochlear News
- 13 days ago - Sensorion Announces Upcoming Presentation of Promising SENS-401 Results at the Next International Conference on Cochlear Implants and Other Implantable Technologies - Business Wire
- 6 weeks ago - Sound Pharmaceuticals' IND Involving Cochlear Implantation Allowed by the FDA - Business Wire
- 3 months ago - How the Victorian government almost killed the next Cochlear - The Australian Financial Review
- 4 months ago - 20 Biggest Health Care Companies in Australia, 2024 - CEOWORLD magazine
- 4 months ago - Cochlear calls for action in Washington D.C. ahead of World Hearing Day - PRNewsWire
- 4 months ago - Cochlear announces 2024 winners of annual scholarships - PRNewsWire
- 4 months ago - Cochlear Limited (CHEOF) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Cochlear’s big first half delivers best dividend in a decade - The Australian Financial Review